MNST
52
6
EQT
48
6
KR
50
4
CFG
40
4
BMY
33
-2
AMGN
46
2
DTE
54
5
COP
39
5
AIG
38
2
EQR
37
3
EIX
62
3
ROK
48
2
BK
61
3
FE
37
3
COF
52
5
NWSA
75
8
TGT
47
3
DVN
22
2
AVGO
79
3
NEE
44
3
MNST
52
6
EQT
48
6
KR
50
4
CFG
40
4
BMY
33
-2
AMGN
46
2
DTE
54
5
COP
39
5
AIG
38
2
EQR
37
3
EIX
62
3
ROK
48
2
BK
61
3
FE
37
3
COF
52
5
NWSA
75
8
TGT
47
3
DVN
22
2
AVGO
79
3
NEE
44
3
Financhill
Back

Roche Holding AG 10K Form

Sell
8

RHHVF
Roche Holding AG

Last Price:
$275.83
Seasonality Move:
0.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RHHVF News And Ratings

See the #1 stock for the next 7 days that we like better than RHHVF

RHHVF Financial Statistics

Sales & Book Value

Annual Sales: $67.3B
Cash Flow: $0
Price / Cash Flow: 17.48
Annual Sales: $40.41
Price / Book: 6.83

Profitability

EPS (TTM): 14.76290
Net Income (TTM): $11.8B
Gross Margin: $49.1B
Return on Equity: 32.32%
Return on Assets: 11.53%

Roche Holding AG Earnings Forecast

Key Roche Holding AG Financial Ratios

  • The Gross Profit Margin over the past 26 years for RHHVF is 72.94%.
  • The Selling, General & Administrative Expenses for RHHVF have been equal to 24.62% of Gross Profit Margin.
  • The Research & Development expenses have been 23.49% of Revenue.
  • The Interest Expense is 8.67% of Operating Income.
  • The Net Earning history of RHHVF is 19.02% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 15 years.

Roche Holding AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RHHVF
Website: roche.com

Debt

Debt-to-Equity Ratio: 1.19
Current Ratio: 1.26
Quick Ratio: 0.8

Price-to-Earnings

Trailing P/E Ratio: 17.31
Forward P/E Ratio: 0

RHHVF Technical Analysis vs Fundamental Analysis

Sell
8
Roche Holding AG (RHHVF) is a Sell

Is Roche Holding AG a Buy or a Sell?

  • Roche Holding AG stock is rated a Sell
    The current Roche Holding AG [RHHVF] share price is $275.83. The Score for RHHVF is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.